Dalong Cao

820 total citations
18 papers, 361 citations indexed

About

Dalong Cao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Dalong Cao has authored 18 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Dalong Cao's work include Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (6 papers) and Prostate Cancer Treatment and Research (4 papers). Dalong Cao is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (6 papers) and Prostate Cancer Treatment and Research (4 papers). Dalong Cao collaborates with scholars based in China and United States. Dalong Cao's co-authors include Yao Zhu, Dingwei Ye, Hai‐Liang Zhang, Yixuan Wang, Xudong Yao, Yiping Zhu, Guohai Shi, Ziliang Wang, Xi Tian and Dingwei Ye and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Dalong Cao

17 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalong Cao China 8 221 148 116 68 46 18 361
Chunlai Lu China 7 381 1.7× 192 1.3× 132 1.1× 86 1.3× 39 0.8× 9 487
Sheng-Bang Yang China 10 218 1.0× 160 1.1× 88 0.8× 81 1.2× 41 0.9× 16 348
Ruiying Sun China 12 206 0.9× 110 0.7× 66 0.6× 54 0.8× 33 0.7× 28 327
Mengxiao Zhu China 12 299 1.4× 122 0.8× 168 1.4× 139 2.0× 48 1.0× 25 478
Binbin Cui China 12 197 0.9× 123 0.8× 56 0.5× 87 1.3× 28 0.6× 20 340
Xianju Qin China 12 260 1.2× 163 1.1× 39 0.3× 70 1.0× 31 0.7× 21 401
Louie Semaan United States 8 169 0.8× 88 0.6× 139 1.2× 106 1.6× 46 1.0× 10 347
Yinmin Gu China 12 235 1.1× 166 1.1× 53 0.5× 71 1.0× 41 0.9× 25 336
Manuel Saiselet Belgium 10 302 1.4× 213 1.4× 60 0.5× 100 1.5× 43 0.9× 13 481
Jingsheng Yuan China 11 256 1.2× 203 1.4× 100 0.9× 57 0.8× 24 0.5× 26 365

Countries citing papers authored by Dalong Cao

Since Specialization
Citations

This map shows the geographic impact of Dalong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalong Cao more than expected).

Fields of papers citing papers by Dalong Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalong Cao. The network helps show where Dalong Cao may publish in the future.

Co-authorship network of co-authors of Dalong Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Dalong Cao. A scholar is included among the top collaborators of Dalong Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalong Cao. Dalong Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Hongkai, Dalong Cao, Márcio Covas Moschovas, et al.. (2025). Early clinical experience with the Carina robotic platform in urologic surgery. BJUI Compass. 6(7). e70050–e70050. 1 indexed citations
2.
Shang, Zhi, Jianji Pan, Shanshan Wang, et al.. (2025). Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial Carcinoma. JCO Precision Oncology. 9(9). e2500195–e2500195.
3.
Xu, Meng, Mengfei Wang, Tao Feng, et al.. (2024). Calycosin inhibits the proliferation and metastasis of renal cell carcinoma through the MAZ/HAS2 signaling pathway. Phytotherapy Research. 38(9). 4774–4791. 5 indexed citations
4.
Zhang, Zi-Hao, Yue Wang, Ya Zhang, et al.. (2023). The function and mechanisms of action of circular RNAs in Urologic Cancer. Molecular Cancer. 22(1). 61–61. 56 indexed citations
5.
Tian, Xi, Wenhao Xu, Fujiang Xu, et al.. (2022). Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response. Annals of Medicine. 54(1). 211–226. 13 indexed citations
6.
Tian, Xi, Wenhao Xu, Aihetaimujiang Anwaier, et al.. (2021). Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real‐world data. Journal of Cellular and Molecular Medicine. 25(8). 3898–3911. 9 indexed citations
7.
Huang, Yongqiang, Shengming Jin, Hailiang Zhang, et al.. (2020). Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 10(3). e120–e120. 3 indexed citations
8.
Ma, Chunguang, Wenhao Xu, Yue Xu, et al.. (2020). Identification and validation of novel metastasis-related signatures of clear cell renal cell carcinoma using gene expression databases.. PubMed. 12(8). 4108–4126. 10 indexed citations
9.
Tian, Xi, Wenhao Xu, Aihetaimujiang Anwaier, et al.. (2020). Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data. OncoImmunology. 9(1). 1784529–1784529. 28 indexed citations
10.
Xu, Wenhao, Yue Xu, Xi Tian, et al.. (2020). Large‐scale transcriptome profiles reveal robust 20‐signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma. Journal of Cellular and Molecular Medicine. 24(16). 9012–9027. 29 indexed citations
11.
Cao, Dalong, Zihao Qi, Yangyang Pang, et al.. (2019). Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer. Cancer Research. 79(10). 2604–2618. 102 indexed citations
12.
Xu, Wenhao, Jun Wang, Yue Xu, et al.. (2019). The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma. Medical Science Monitor. 25. 9458–9470. 7 indexed citations
13.
Cao, Dalong, Yuanyuan Qu, Xuan Zhang, et al.. (2018). High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma. Journal of Cancer. 9(18). 3400–3406. 2 indexed citations
14.
Cao, Dalong, Chengyuan Gu, Dingwei Ye, Bo Dai, & Yao Zhu. (2018). PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population. International braz j urol. 44(3). 500–505. 4 indexed citations
15.
Ye, Dingwei, Xudong Yao, Gongxian Wang, et al.. (2017). An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial.. Journal of Clinical Oncology. 35(6_suppl). 303–303. 3 indexed citations
16.
Shi, Guohai, Xiaoqun Yang, Bo Dai, et al.. (2014). Clinical significance of TMPRSS4 in prostate cancer.. PubMed. 7(11). 8053–8. 5 indexed citations
17.
Cao, Dalong, Dingwei Ye, Hai‐Liang Zhang, et al.. (2010). A multiplex model of combining gene‐based, protein‐based, and metabolite‐based with positive and negative markers in urine for the early diagnosis of prostate cancer. The Prostate. 71(7). 700–710. 78 indexed citations
18.
Cao, Dalong & Xudong Yao. (2010). Advances in biomarkers for the early diagnosis of prostate cancer. Chinese Journal of Cancer. 29(2). 229–233. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunlai Lu Breakdown of academic impact, for papers by Sheng-Bang Yang Breakdown of academic impact, for papers by Ruiying Sun Breakdown of academic impact, for papers by Mengxiao Zhu Breakdown of academic impact, for papers by Binbin Cui Breakdown of academic impact, for papers by Xianju Qin Breakdown of academic impact, for papers by Louie Semaan Breakdown of academic impact, for papers by Yinmin Gu Breakdown of academic impact, for papers by Manuel Saiselet Breakdown of academic impact, for papers by Jingsheng Yuan
Rankless by CCL
2026